Diagnosis and treatment of disease caused by nontuberculous mycobacteria.

Diagnostic Criteria of Nontuberculous Mycobacterial Lung Disease For patients with a cavitary infiltrate: Two or more sputums or bronchial washings that are acid-fast bacilli smear positive and/or produce moderate to heavy growth on culture.Exclusion of other reasonable causes for the disease.II. For patients with a noncavitary infiltrate: Two or more sputums or bronchial washings that are acid-fast bacilli smear positive and/or produce moderate to heavy growth on culture.The isolate is Mycobacterium avium complex or M. kansasii and cannot be cleared from the sputum with either bronchial hygiene or 2 wk of drug therapy.Exclusion of other reasonable causes for the disease.For patients with a cavitary or noncavitary infiltrate whose sputum evaluations are nondiagnostic or another disease cannot be excluded: 1. Lung biopsy yields a NTM.2. The biopsy shows mycobacterial histopathologic features (i.e., granulomatous inflammation) and two or more sputums are positive for a NTM even in low numbers.

[1]  R. Altman,et al.  Chronic lymphadenopathy due to mycobacterial infection. Clinical features, diagnosis, histopathology, and management. , 1984, American journal of diseases of children.

[2]  R. O'brien,et al.  Usefulness of skin testing with mycobacterial antigens in children with cervical lymphadenopathy , 1992, The Pediatric infectious disease journal.

[3]  J. Falkinham,et al.  Plasmid DNA profiles as epidemiological markers for clinical and environmental isolates of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum. , 1986, The Journal of infectious diseases.

[4]  R. Wallace,,et al.  Bacteremia caused by a previously unidentified species of rapidly growing Mycobacterium successfully treated with vancomycin. , 1983, Annals of internal medicine.

[5]  C. Woodley,et al.  Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. , 1985, The Journal of infectious diseases.

[6]  J. Musser,et al.  Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. , 1989, The Journal of infectious diseases.

[7]  M. D. Del Beccaro,et al.  Diagnostic usefulness of mycobacterial skin test antigens in childhood lymphadenitis. , 1989, The Pediatric infectious disease journal.

[8]  R. Wallace,,et al.  Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid , 1991, Antimicrobial Agents and Chemotherapy.

[9]  M. Luquin,et al.  Mycobacterium xenopi infections in the acquired immunodeficiency syndrome. , 1988, Annals of internal medicine.

[10]  L. Hoover,et al.  Cervical mycobacterial lymphadenitis. Medical vs surgical management. , 1985, Archives of otolaryngology.

[11]  R. Bolan,et al.  Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS , 1991, The Lancet.

[12]  R. Kim Tetracycline Therapy for Atypical Mycobacterial Granuloma , 1974 .

[13]  G. Bodey,et al.  Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters. , 1987, The American journal of medicine.

[14]  K J Ryan,et al.  Antimicrobial Susceptibility Testing , 2016, Advances in Experimental Medicine and Biology.

[15]  J. Steadham High-catalase strains of Mycobacterium kansasii isolated from water in Texas , 1980, Journal of clinical microbiology.

[16]  P. Jenkins,et al.  Pulmonary infection with mycobacterium xenopi: review of treatment and response. , 1984, Thorax.

[17]  R. Wallace,,et al.  Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. , 1983, Annals of internal medicine.

[18]  M. Iseman,et al.  Disseminated Infection with Mycobacterium avium‐intracellulare: A REPORT OF 13 CASES AND A REVIEW OF THE LITERATURE , 1985, Medicine.

[19]  C. Collins,et al.  Mycobacterium marinum infections in man , 1985, Journal of Hygiene.

[20]  M. Rodriguez‐Barradas,et al.  Disseminated Mycobacterium fortuitum disease in an AIDS patient. , 1992, The American journal of medicine.

[21]  J. Grosset,et al.  Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection. , 1988, Tubercle.

[22]  A. A. Mel’nikova,et al.  [Culture media for detection of antibiotic substances in actinomycetes]. , 1957, Mikrobiologiia.

[23]  R. Wallace,,et al.  Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms , 1992, Antimicrobial Agents and Chemotherapy.

[24]  Horsburgh Cr,et al.  The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). , 1989 .

[25]  L. Heifets MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs , 1988, Antimicrobial Agents and Chemotherapy.

[26]  D. Snider,et al.  Rifabutin (ansamycin LM 427): a new rifamycin-S derivative for the treatment of mycobacterial diseases. , 1987, Reviews of Infectious Diseases.

[27]  R. Schelonka,et al.  Disseminated Mycobacterium avium complex in non-human immunodeficiency virus-infected pediatric patients. , 1992, The Pediatric infectious disease journal.

[28]  P. Jenkins,et al.  Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria. , 1987, Thorax.

[29]  E. Wolinsky,et al.  Mycobacteria in soil and their relation to disease-associated strains. , 2015, The American review of respiratory disease.

[30]  M. Iseman,et al.  Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing. , 2015, The American review of respiratory disease.

[31]  J. Hawkins,et al.  Evaluation of a simple method for growing Mycobacterium haemophilum , 1985, Journal of clinical microbiology.

[32]  M. Corrado,et al.  Mycobacterium thermoresistibile: a new pathogen for humans , 1981, Journal of clinical microbiology.

[33]  D. R. Deyoung,et al.  In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii , 1984, Antimicrobial Agents and Chemotherapy.

[34]  G. Mccracken,et al.  Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. , 1979, The Journal of pediatrics.

[35]  Wallace Rj The clinical presentation, diagnosis, and therapy of cutaneous and pulmonary infections due to the rapidly growing mycobacteria, M. fortuitum and M. chelonae. , 1989 .

[36]  V. Pryor,et al.  Outbreak of Mycobacterium chelonae infection associated with use of jet injectors. , 1990, JAMA.

[37]  S. Jay,et al.  The course of untreated Mycobacterium kansasii disease. , 1975, The American review of respiratory disease.

[38]  D. Armstrong,et al.  Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. , 1986, Annals of internal medicine.

[39]  C. Smith,et al.  A limited clinical, pathologic, and epidemiologic study of patients with pulmonary lesions associated with atypical acid-fast bacilli in the sputum. , 1957, American review of tuberculosis.

[40]  F. Morinet,et al.  Erythroid hypoplasia due to chronic infection with parvovirus B19. , 1990, The New England journal of medicine.

[41]  A. Teirstein,et al.  Solitary pulmonary nodules due to nontuberculous mycobacterial infection. , 1981, The American journal of medicine.

[42]  C. Palmer,et al.  An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. , 1969, The American review of respiratory disease.

[43]  A. Haemers,et al.  Mycobacteria and the new quinolones , 1989, Antimicrobial Agents and Chemotherapy.

[44]  D. Snider,et al.  Isolation of nontuberculous mycobacteria in the United States, 1980. , 1982, The Journal of infectious diseases.

[45]  C Thornsberry,et al.  Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae , 1985, Antimicrobial Agents and Chemotherapy.

[46]  R. Good,et al.  Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. , 1982, The Journal of infectious diseases.

[47]  Nalin Rastogi,et al.  Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents? , 1981, Antimicrobial Agents and Chemotherapy.

[48]  R. Wallace,,et al.  Human disease due to Mycobacterium smegmatis. , 1988, The Journal of infectious diseases.

[49]  B. Parker,et al.  Recent experience in the epidemiology of disease caused by atypical mycobacteria. , 1981, Reviews of infectious diseases.

[50]  W. Johanson,et al.  Mycobacterium simiae. Clinical features and follow-up of twenty-four patients. , 1983, The American review of respiratory disease.

[51]  R. Corpe Surgical management of pulmonary disease due to Mycobacterium avium-intracellulare. , 1981, Reviews of infectious diseases.

[52]  S. Eykyn,et al.  The successful treatment of tropical fish tank granuloma (Mycobacterium marinum) with co‐trimoxazole , 1977, The British journal of dermatology.

[53]  L. Christianson,et al.  Pulmonary disease in adults associated with unclassified mycobacteria. , 1960, The American journal of medicine.

[54]  A. Armstrong,et al.  A clinical study of the chronic lung disease due to nonphotochromogenic acid-fast bacilli. , 1960, Annals of internal medicine.

[55]  G. Meissner,et al.  Sources of Mycobacterium avium complex infection resulting in human diseases. , 1977, The American review of respiratory disease.

[56]  Grossman Wm,et al.  Origin and significance of mycobacterium xenopi in clinical specimens. I. Water as a source of contamination. , 1976 .

[57]  R. Good,et al.  Spectrum of disease due to rapidly growing mycobacteria. , 1983, Reviews of infectious diseases.

[58]  M. Iseman,et al.  Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections. , 1991, The Annals of thoracic surgery.

[59]  J. Raleigh,et al.  Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin. , 1981, Reviews of infectious diseases.

[60]  P. Davidson,et al.  Treatment of disease due to Mycobacterium intracellulare. , 1981, Reviews of infectious diseases.

[61]  E. H. Runyon,et al.  The relationship of atypical acid-fast bacteria to human disease; a preliminary report. , 1954, The Journal of laboratory and clinical medicine.

[62]  J. Simmank,et al.  Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex. , 1985, Diagnostic microbiology and infectious disease.

[63]  C. Palmer,et al.  Epidemiologic studies of tuberculin sensitivity. I. Preliminary results with purified protein derivatives prepared from atypical acid-fast organisms. , 1958, American journal of hygiene.

[64]  N. D’Esopo,et al.  Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi. , 2015, The American review of respiratory disease.

[65]  R. Selik,et al.  The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). , 1989, The American review of respiratory disease.

[66]  R. Wallace,,et al.  Mycobacterium chelonae causing otitis media in an ear-nose-and-throat practice. , 1988, The New England journal of medicine.

[67]  S. Siddiqi,et al.  Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p-nitro-alpha-acetylamino-beta-hydroxypropiophenone , 1984, Journal of clinical microbiology.

[68]  P. Jenkins,et al.  Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response. , 1983, Thorax.

[69]  R. Good,et al.  Nosocomial Mycobacterium fortuitum colonization from a contaminated ice machine. , 1988, The American review of respiratory disease.

[70]  M. Iseman,et al.  Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods , 1985, Antimicrobial Agents and Chemotherapy.

[71]  George Tk,et al.  Disseminated infection with Mycobacterium avium-intracellulare. , 1984 .

[72]  J. McCutchan,et al.  Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group. , 1990, Annals of internal medicine.

[73]  R. Wallace,,et al.  Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics , 1983, Antimicrobial Agents and Chemotherapy.

[74]  R. Wallace,,et al.  Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. , 1981, Reviews of infectious diseases.

[75]  G. L. White,et al.  Atypical mycobacterial infection caused by Mycobacterium marinum. , 1990, The New England journal of medicine.

[76]  J. McCormack,et al.  Bacteremia caused by Mycobacterium neoaurum , 1988, Journal of clinical microbiology.

[77]  C. Collins,et al.  The isolation of M. kansasii and M. xenopi from water systems. , 1974, Tubercle.

[78]  M. Ali,et al.  Fine needle aspiration biopsy in the diagnosis of tuberculosis. , 1985, Acta cytologica.

[79]  W. Baine,et al.  Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. , 1983, The Journal of infectious diseases.

[80]  L. Bland,et al.  Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. , 1987, The New England journal of medicine.

[81]  J. Kilburn,et al.  High-performance liquid chromatography of mycolic acids as a tool in the identification of Corynebacterium, Nocardia, Rhodococcus, and Mycobacterium species , 1986, Journal of clinical microbiology.

[82]  D. Snider,et al.  The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. , 1987, The American review of respiratory disease.

[83]  K. K. Lai,et al.  Mycobacterial Cervical Lymphadenopathy: Relation of Etiologic Agents to Age , 1984 .

[84]  M. Luquin,et al.  In vitro activity of clofazimine against rapidly growing nonchromogenic mycobacteria , 1986, Antimicrobial Agents and Chemotherapy.

[85]  Horsburgh Cr Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. , 1991, The New England journal of medicine.

[86]  D. Murphy,et al.  A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex. , 2015, The American review of respiratory disease.

[87]  L. Grayson,et al.  Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients. , 1990, The Journal of infectious diseases.

[88]  W. Sealy,et al.  Long-term results of pulmonary resection for atypical mycobacterial disease. , 1983, The Annals of thoracic surgery.

[89]  D. Peterson,et al.  Infection with Mycobacterium avium complex in patients without predisposing conditions. , 1989, The New England journal of medicine.

[90]  S. Ahn,et al.  Chemotherapy for pulmonary disease due to Mycobacterium kansasii: efficacies of some individual drugs. , 1981, Reviews of infectious diseases.

[91]  F. Kuze,et al.  In vitro and in vivo susceptibility of atypical mycobacteria to various drugs. , 1981, Reviews of infectious diseases.

[92]  C. Collins,et al.  Thenatureofmycobacterial disease insoutheast England, 1977-84 , 1986 .

[93]  R. Macgregor,et al.  Mycobacterial infections in renal transplant recipients: report of five cases and review of the literature. , 1983, Reviews of infectious diseases.

[94]  W. Stead,et al.  Long-term results of medical treatment in Mycobacterium intracellulare infection. , 1979, The American journal of medicine.

[95]  S. Ahn,et al.  Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii. , 1983, The American review of respiratory disease.

[96]  W. Schaffner,et al.  Mycobacterium chelonae: a cause of nodular skin lesions with a proclivity for renal transplant recipients. , 1989, The American journal of medicine.

[97]  L. Heifets Synergistic effect of rifampin, streptomycin, ethionamide, and ethambutol on Mycobacterium intracellulare. , 2015, The American review of respiratory disease.

[98]  W. Lester Treatment of drug-resistant tuberculosis. , 1971, Disease-a-month : DM.

[99]  R. Wallace,,et al.  Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. , 1985, The Journal of infectious diseases.

[100]  P. Loria Minocycline hydrochloride treatment for atypical acid-fast infection. , 1976, Archives of dermatology.

[101]  F. Kocka,et al.  Disseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome. , 1986, Annals of internal medicine.

[102]  F. Robicsek,et al.  Two outbreaks of sternal wound infection due to organisms of the Mycobacterium fortuitum complex. , 1981, The Journal of infectious diseases.

[103]  W. Bailey,et al.  Surgical treatment of atypical mycobacterial lymphadenitis in children. , 1985, Pediatric infectious disease.

[104]  D. Rimland,et al.  Infections caused by Mycobacterium szulgai in humans. , 1987, Reviews of infectious diseases.

[105]  A. Lavy,et al.  Isolation of Mycobacterium simiae from clinical specimens in Israel. , 1982, Tubercle.

[106]  W. Yew,et al.  Combined use of fine-needle aspiration cytologic examination and tuberculin skin test in the diagnosis of cervical tuberculous lymphadenitis. A prospective study. , 1991, Archives of otolaryngology--head & neck surgery.

[107]  E. Wolinsky Nontuberculous mycobacteria and associated diseases. , 2015, The American review of respiratory disease.

[108]  R. Wallace,,et al.  Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasii. , 2015, The American review of respiratory disease.

[109]  P. Jenkins,et al.  Pulmonary infection with Mycobacterium malmoense--a review of treatment and response. , 1985, Tubercle.

[110]  C. Collins,et al.  Mycobacteria in water. , 1984, The Journal of applied bacteriology.

[111]  E. Lincoln,et al.  Disease in children due to mycobacteria other than Mycobacterium tuberculosis. , 2015, The American review of respiratory disease.

[112]  E. Baron,et al.  Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome. , 1986, Diagnostic microbiology and infectious disease.

[113]  B. Dautzenberg,et al.  Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. , 1991, The American review of respiratory disease.

[114]  D. Dawson,et al.  Investigation by seroagglutination of strains of the Mycobacterium intracellulare-M. scrofulaceum group from house dusts and sputum in Southeastern Queensland. , 1971, The American review of respiratory disease.

[115]  R. Wallace,,et al.  The clinical presentation, diagnosis, and therapy of cutaneous and pulmonary infections due to the rapidly growing mycobacteria, M. fortuitum and M. chelonae. , 1989, Clinics in chest medicine.

[116]  R. Johnson,et al.  Mycobacterium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting. , 1991, The American review of respiratory disease.

[117]  R. W. James,et al.  Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children. , 1992, The Journal of pediatrics.

[118]  Philip Smith,et al.  Therapy of Mycobacterium marinum infections. Use of tetracyclines vs rifampin. , 1986, Archives of internal medicine.

[119]  R. Wallace,,et al.  Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks , 1992, Journal of clinical microbiology.

[120]  M. Iseman,et al.  Determination of in vitro susceptibility of mycobacteria to ansamycin. , 2015, The American review of respiratory disease.

[121]  R. Wallace,,et al.  Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. , 1992, The Journal of infectious diseases.

[122]  S. P. Chow,et al.  Mycobacterium marinum infection of the hand and wrist. Results of conservative treatment in twenty-four cases. , 1987, The Journal of bone and joint surgery. American volume.

[123]  C. Woodley,et al.  In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin. , 1982, The American review of respiratory disease.

[124]  P M Southern,et al.  Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. , 1992, The Journal of infectious diseases.

[125]  R. Johnson,et al.  Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. , 1992, Chest.

[126]  M. Samadpour,et al.  Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients , 1992, Journal of clinical microbiology.